Chen et al. [30] retrospectively analyzed the clinical data of 599 patients with advanced CRC and found that apoB/apoA1 ≥ 0.63 was an independent risk factor for poor survival in patients without liver metastases. This evidence concerns the gene APOB and colorectal carcinoma.